Earnings Calls

Citigroup has beaten EPS estimates in the majority of recent quarters, though the magnitude of this quarter's $0.46 beat (17.7% above consensus) ranks among its largest surprises in the past two years. Historically, Citigroup's post-earnings moves have averaged in the low single digits, making the +4.3% next-day rally consistent with prior strong-beat reactions. The stock's trajectory into earnings had been subdued relative to peers, which may have contributed to a more pronounced reaction on the upside.

Analysts are focused on Citigroup's progress on its multi-year transformation plan, including expense reduction targets, return-on-tangible-common-equity (ROTCE) trajectory, and the pace of divestitures from non-core international consumer businesses. Net interest income trends and credit quality in the consumer and institutional lending books are key variables for forward estimate revisions. Management commentary on capital return plans — including buyback capacity under current capital ratios — likely drew significant attention on the call.

Johnson & Johnson has a long track record of narrow EPS beats, and this quarter's $0.02 beat is consistent with the company's typical pattern of modest outperformance on the bottom line. However, the $400M revenue miss is notable — JNJ has generally met or exceeded top-line estimates in recent quarters, making this shortfall a departure from trend. Post-earnings moves for JNJ tend to be muted given its defensive profile, but the -5.0% weekly decline is larger than its typical post-report range.

The market is focused on JNJ's full-year revenue and adjusted EPS guidance, particularly regarding the growth trajectory of its MedTech and Innovative Medicine segments following its separation from the consumer health business. Analysts are tracking the impact of biosimilar competition on key pharmaceutical franchises and the ramp of recently launched drugs. Commentary on litigation reserves related to talc and other legacy liabilities remains a persistent area of scrutiny for forward modeling.

JPMorgan has consistently beaten EPS estimates over the past several years, and this quarter's $0.43 beat (7.8% above consensus) is in line with the bank's pattern of meaningful outperformance. However, JPM shares have historically shown a 'sell the news' tendency following earnings, particularly when the stock has appreciated significantly heading into the report. The -2.5% next-day decline despite a strong beat fits this historical pattern of muted or negative reactions on strong prints.

Analysts are focused on JPMorgan's updated net interest income outlook for full-year 2026, given the sensitivity of the bank's earnings to rate curve movements and deposit pricing dynamics. The trajectory of investment banking and trading revenue — particularly in a volatile macro environment — is a key swing factor for forward estimates. CEO commentary on credit quality trends, reserve builds, and the broader economic outlook typically sets the tone for the entire banking sector's forward expectations.

Wells Fargo missed EPS estimates by $0.04 (2.5%), breaking a pattern of recent beats and representing one of the bank's weaker quarterly prints relative to expectations. The -7.3% next-day decline is outsized compared to WFC's typical post-earnings moves, which have generally been in the 2-4% range in either direction. The severity of the reaction suggests the miss was compounded by other factors disclosed during the report or call.

The market is focused on Wells Fargo's net interest income trajectory, particularly as the bank operates under the Federal Reserve's asset cap, which constrains balance sheet growth and limits NII upside relative to peers. Progress on expense efficiency and the timeline for potential asset cap removal remain the most closely watched forward catalysts. Analysts are also tracking the pace of non-interest income diversification — particularly in investment banking and advisory — as a lever to offset NII headwinds.

Bank of America has now beaten EPS estimates for four consecutive quarters, and this quarter's $0.09 beat (8.8% above consensus) is consistent with the bank's recent trend of mid-to-high single-digit surprises. BAC's post-earnings reactions have been mixed in recent quarters, with beats not always translating into sustained moves. The muted +0.3% next-day move and -0.5% weekly return this quarter follow that pattern of limited price response to earnings beats.

Analysts are focused on Bank of America's net interest income outlook, given the bank's significant asset sensitivity and the degree to which rate changes flow through its large deposit base. The trajectory of consumer credit quality — including charge-off rates in credit cards and auto loans — is a key variable for provision expense modeling. Wealth management revenue trends through Merrill Lynch and the private bank division are also being closely monitored as a differentiator for BAC's earnings mix.

Kinder Morgan reported revenue of $4.5B that narrowly missed the $4.5B estimate when measured to additional decimal precision, essentially an inline print on the top line. KMI's post-earnings reactions have historically been subdued, typically moving less than 1% in either direction, consistent with its midstream infrastructure business model and dividend-focused investor base. The +0.4% next-day and +0.6% weekly moves are in line with this low-volatility post-earnings pattern.

The market is focused on Kinder Morgan's distributable cash flow and dividend coverage ratio, which are the primary valuation drivers for midstream companies. Analysts are tracking the status of expansion projects — particularly in natural gas pipelines serving LNG export terminals and data center power demand — as key growth catalysts for the capital plan. Management's commentary on volume trends across natural gas transport, CO2, and products segments informs the trajectory of EBITDA and DCF estimates.

Morgan Stanley has now beaten EPS estimates for four consecutive quarters, and this quarter's $0.41 beat (13.6% above consensus) is the largest in that streak. Historically, MS shares have responded positively to meaningful EPS beats, particularly when driven by strength in wealth management or institutional securities. The +4.5% after-hours move that held through the week is on the higher end of MS's typical post-earnings reaction range.

Analysts are focused on the durability of Morgan Stanley's wealth management net new asset flows, which are the primary driver of the stock's premium valuation relative to pure-play investment banks. Trading and investment banking revenue trends — particularly in equity underwriting and M&A advisory — are key swing factors given macro uncertainty. Management commentary on compensation ratios and operating leverage across the institutional securities division influences forward margin estimates.

PNC Financial has now beaten EPS estimates for four consecutive quarters, with this quarter's $0.16 beat (3.8% above consensus) representing a moderate surprise that is typical of the company's recent trend. PNC's post-earnings reactions have historically been mixed, with next-day moves often muted before the stock drifts in the following days. The pattern this quarter — a flat-to-slightly-negative next day followed by a +2.4% weekly gain — is consistent with that gradual digestion pattern.

Analysts are focused on PNC's net interest income and net interest margin outlook, particularly given the regional bank's sensitivity to the rate environment and competitive deposit pricing dynamics. Fee income growth from treasury management, capital markets, and advisory services is a key differentiator PNC has emphasized, and forward estimates reflect expectations for continued expansion in these areas. Credit quality trends in commercial real estate and middle-market lending portfolios are closely monitored for any signs of deterioration.

Abbott Laboratories reported EPS exactly inline with the $1.15 consensus estimate, a result that historically has produced flat-to-slightly-negative reactions for the company. However, the -4.7% next-day decline and -9.4% weekly loss are significantly more severe than ABT's typical post-earnings moves, which have generally remained within a 2-3% range in either direction. The magnitude of this selloff suggests the inline print was viewed as a disappointment relative to buy-side expectations or that forward-looking disclosures were the primary driver.

The market is focused on Abbott's full-year adjusted EPS and organic revenue growth guidance, with particular attention to the trajectory of the medical devices segment, which has been the primary growth engine. Analysts are tracking the ramp of continuous glucose monitoring (Libre franchise) adoption and the competitive landscape in diagnostics following the post-pandemic normalization of COVID testing revenue. Margin expansion potential and the impact of new product launches across structural heart and electrophysiology portfolios are key inputs to forward models.

Netflix missed on both EPS ($1.23 vs. $1.34) and revenue ($12.2B vs. $12.6B), a rare double miss for a company that has beaten estimates in the majority of recent quarters. Netflix's post-earnings moves have historically been among the most volatile in large-cap tech, with 10%+ swings not uncommon. The -9.7% next-day decline and -13.6% weekly loss are on the severe end but not unprecedented for NFLX following a disappointing quarter.

Analysts are focused on Netflix's next-quarter and full-year revenue guidance, subscriber growth metrics (though the company has de-emphasized headline subscriber counts in favor of revenue and operating margin), and the ad-tier monetization trajectory. The pace of average revenue per member growth and the contribution of the advertising business to the revenue mix are key variables driving forward estimate revisions. Content spend levels and their impact on operating margins remain the primary debate among analysts modeling Netflix's earnings power.

Travelers has now beaten both EPS and revenue estimates for four consecutive quarters, with this quarter's $0.63 EPS beat (8.9% above consensus) and $900M revenue beat (8.2% above) representing a strong double beat. TRV's post-earnings reactions have historically been moderate despite frequent beats, partly reflecting the stock's 'hold' consensus and the cyclical nature of insurance underwriting results. The +0.5% next-day move and +0.6% weekly gain are consistent with this pattern of muted price responses even on strong prints.

The market is focused on Travelers' combined ratio trajectory, net written premium growth, and the sustainability of favorable prior-year reserve development that has boosted recent results. Catastrophe loss levels and the pricing environment in commercial and personal lines are key variables that drive forward estimates for underwriting profitability. Investment income trends, which are influenced by the rate environment and the company's fixed-income portfolio duration, also feature prominently in analyst models.

U.S. Bancorp has now beaten EPS estimates for four consecutive quarters, with this quarter's $0.04 beat (3.5% above consensus) representing a modest surprise consistent with the company's recent pattern of narrow outperformance. USB's post-earnings reactions have been generally muted in recent quarters, with next-day moves typically in the 1-2% range. The initial -1.6% after-hours decline that reversed to +1.0% the next day and +0.5% for the week follows a pattern of after-hours volatility that stabilizes quickly.

Analysts are focused on U.S. Bancorp's net interest income and fee revenue trajectory, particularly as the bank continues to integrate Union Bank and realizes merger-related cost synergies. The pace of expense reduction and the timeline to achieve targeted efficiency ratios are key forward catalysts. Credit quality trends across consumer and commercial portfolios — and the associated provision expense outlook — are the primary variables driving divergence in analyst estimates for the coming quarters.